Myomo Inc (MYO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Myomo Inc (MYO) has a cash flow conversion efficiency ratio of -0.244x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.20 Million) by net assets ($9.00 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MYO equity to assets ratio to measure how much of total assets are equity-financed.
Myomo Inc - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Myomo Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check total reinvestment intensity of Myomo Inc to assess the company's total reinvestment commitment from operating cash flow.
Myomo Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Myomo Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Take Solutions Limited
NSE:TAKE
|
-0.122x |
|
Havila Shipping ASA
OL:HAVI
|
0.404x |
|
Itama Ranoraya
JK:IRRA
|
-0.486x |
|
BYC Co Ltd
KO:001465
|
0.030x |
|
Dongil Metal Co. Ltd
KQ:109860
|
-0.006x |
|
Milae Bioresources Co. Ltd
KQ:218150
|
-0.011x |
|
TJ media Co. Ltd
KQ:032540
|
0.033x |
|
Y-S Electronic Co Ltd
TWO:6418
|
0.020x |
Annual Cash Flow Conversion Efficiency for Myomo Inc (2014–2025)
The table below shows the annual cash flow conversion efficiency of Myomo Inc from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Myomo Inc (MYO) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $11.40 Million | $-14.51 Million | -1.273x | -855.95% |
| 2024-12-31 | $24.71 Million | $-3.29 Million | -0.133x | +80.61% |
| 2023-12-31 | $8.99 Million | $-6.17 Million | -0.687x | +57.33% |
| 2022-12-31 | $6.36 Million | $-10.23 Million | -1.609x | -159.71% |
| 2021-12-31 | $15.41 Million | $-9.55 Million | -0.620x | +20.67% |
| 2020-12-31 | $11.57 Million | $-9.03 Million | -0.781x | +86.22% |
| 2019-12-31 | $1.82 Million | $-10.34 Million | -5.668x | -279.12% |
| 2018-12-31 | $6.43 Million | $-9.61 Million | -1.495x | -202.36% |
| 2017-12-31 | $12.45 Million | $-6.15 Million | -0.494x | -370.63% |
| 2016-12-31 | $-17.53 Million | $-3.20 Million | 0.183x | -92.67% |
| 2015-12-31 | $-1.34 Million | $-3.33 Million | 2.492x | +169.67% |
| 2014-12-31 | $712.11K | $-2.55 Million | -3.577x | -- |
About Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.… Read more